Literature DB >> 18711727

Effects of maternal antenatal glucocorticoid treatment on apoptosis in the ovine fetal cerebral cortex.

Shadi N Malaeb1, Virginia Hovanesian, Matthew D Sarasin, Silvia M Hartmann, Grazyna B Sadowska, Barbara S Stonestreet.   

Abstract

We examined the effects of single and multiple maternal glucocorticoid courses on apoptosis in the cerebral cortices of ovine fetuses (CC). Ewes received single dexamethasone or placebo courses at 104-106 or 133-135 days or multiple courses between 76-78 and 104-106 days gestation. In the single-course groups, ewes received four 6 mg dexamethasone or placebo injections every 12 hr for 48 hr. Multiple-course groups received the same treatment once per week for 5 weeks. Neuronal and nonneuronal apoptotic cell numbers per square millimeter were determined with TUNEL and NeuN staining and with caspase-3 enzyme activity on CC tissues harvested at 106-108 (70%) or 135-137 (90%) days of gestation. Apoptotic cell numbers and caspase-3 activity were 50% lower (P < 0.02) after single placebo courses at 90% than 70% gestation; 90% of apoptotic cells were (P < 0.01) nonneuronal at both ages. Nonneuronal apoptotic cells and caspase-3 activity were 40% and 20% lower (P < 0.02) after single dexamethasone than placebo courses at 70%, but not 90%, gestation. Caspase-3 activity was 20% lower (P < 0.01) after multiple dexamethasone than placebo courses, but apoptotic cell number did not differ. We conclude that nonneuronal apoptosis represents the major form of apoptosis in the CC at both 70% and 90% of gestation. Apoptosis in nonneuronal cells decreases with maturity and after a single course of dexamethasone at 70%, but not at 90%, gestation and not after multiple courses at 70% gestation. We speculate that a single course of glucocorticoids exerts maturational changes on the rate of apoptosis in the cerebral cortex of preterm ovine fetuses. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18711727      PMCID: PMC2692887          DOI: 10.1002/jnr.21825

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  56 in total

1.  Non-linear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep.

Authors:  M Schwab; K Schmidt; M Roedel; T Mueller; H Schubert; M A Anwar; P W Nathaniels
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 2.  Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000.

Authors: 
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

3.  Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep.

Authors:  M Schwab; I Antonow-Schlorke; B Kühn; T Müller; H Schubert; B Walter; U Sliwka; P W Nathanielsz
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

4.  Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders.

Authors:  L E Haynes; M R Griffiths; R E Hyde; D J Barber; I J Mitchell
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives.

Authors:  O Baud; V Laudenbach; P Evrard; P Gressens
Journal:  Pediatr Res       Date:  2001-12       Impact factor: 3.756

Review 6.  Antenatal therapies and the developing brain.

Authors:  D F Adams; L R Ment; B Vohr
Journal:  Semin Neonatol       Date:  2001-04

7.  Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway.

Authors:  J L Hall; C M Matter; X Wang; G H Gibbons
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

8.  Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow.

Authors:  M Schwab; M Roedel; M A Anwar; T Müller; H Schubert; L F Buchwalder; B Walter; W Nathalielsz
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

9.  Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.

Authors:  S A Back; N L Luo; N S Borenstein; J M Levine; J J Volpe; H C Kinney
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

10.  Dexamethasone induces dendritic alteration but not apoptosis in the neurons of the hippocampus in postnatal rats.

Authors:  C K Tan; J Yan; C Ananth; C Kaur
Journal:  Neurosci Lett       Date:  2002-07-05       Impact factor: 3.046

View more
  12 in total

1.  Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus.

Authors:  Xiaodi Chen; Virginia Hovanesian; Syed Naqvi; Yow-Pin Lim; Richard Tucker; John E Donahue; Edward G Stopa; Barbara S Stonestreet
Journal:  Brain Behav Immun       Date:  2017-08-02       Impact factor: 7.217

2.  Na+,K+-ATPase activity and subunit protein expression: ontogeny and effects of exogenous and endogenous steroids on the cerebral cortex and renal cortex of sheep.

Authors:  Chang-Ryul Kim; Grazyna B Sadowska; Stephanie A Newton; Maricruz Merino; Katherine H Petersson; James F Padbury; Barbara S Stonestreet
Journal:  Reprod Sci       Date:  2010-10-19       Impact factor: 3.060

3.  Postnatal glucocorticoid-induced hypomyelination, gliosis, and neurologic deficits are dose-dependent, preparation-specific, and reversible.

Authors:  Muhammad T K Zia; Govindaiah Vinukonda; Linnea R Vose; Bala B R Bhimavarapu; Sanda Iacobas; Nishi K Pandey; Ann Marie Beall; Preeti Dohare; Edmund F LaGamma; Dumitru A Iacobas; Praveen Ballabh
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

4.  Maternal treatment with glucocorticoids modulates gap junction protein expression in the ovine fetal brain.

Authors:  G B Sadowska; B S Stonestreet
Journal:  Neuroscience       Date:  2014-06-11       Impact factor: 3.590

5.  Effect of prenatal glucocorticoids on cerebral vasculature of the developing brain.

Authors:  Govindaiah Vinukonda; Krishna Dummula; Sabrina Malik; Furong Hu; Carl I Thompson; Anna Csiszar; Zoltan Ungvari; Praveen Ballabh
Journal:  Stroke       Date:  2010-07-08       Impact factor: 7.914

6.  Ontogeny of tight junction protein expression in the ovine cerebral cortex during development.

Authors:  G B Sadowska; N Ahmedli; X Chen; B S Stonestreet
Journal:  Neuroscience       Date:  2015-09-28       Impact factor: 3.590

7.  Neuron deficit in the white matter and subplate in periventricular leukomalacia.

Authors:  Hannah C Kinney; Robin L Haynes; Gang Xu; Sarah E Andiman; Rebecca D Folkerth; Lynn A Sleeper; Joseph J Volpe
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

Review 8.  Steroids and injury to the developing brain: net harm or net benefit?

Authors:  Shadi N Malaeb; Barbara S Stonestreet
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

9.  Prenatal betamethasone does not affect glutamatergic or GABAergic neurogenesis in preterm newborns.

Authors:  L R Vose; G Vinukonda; D Diamond; R Korumilli; F Hu; M T K Zia; R Hevner; P Ballabh
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

10.  High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats.

Authors:  Xiaodi Chen; Jiyong Zhang; Boram Kim; Siddhant Jaitpal; Steven S Meng; Kwame Adjepong; Sayumi Imamura; Hidenori Wake; Masahiro Nishibori; Edward G Stopa; Barbara S Stonestreet
Journal:  Exp Neurol       Date:  2018-09-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.